Full Text
CO78 Efficacy and Safety of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Systematic Review and Meta-Analysis

Abstract

Authors

J Li P Xing X Hao X Zhang

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×